Amyotrophic Lateral Sclerosis Identified™ Program

Sponsored, no-charge genetic testing
US

ALS Identified Program Logo

What is Amyotrophic Lateral Sclerosis (ALS)?

  • In the US, there are about 1.94 new cases per 100,000 people per year, with more than 6250 individuals in the US diagnosed with ALS each year.1
  • ALS is a devastating disease that places a tremendous emotional and physical burden on patients, their families and their caregivers.2
  • Early diagnosis, include genetic testing, and healthcare interventions are extremely important to the health of a person with ALS.3
Order nowRequest a kit

Increasing access to genetic testing and counseling

May help inform understanding and life choices

Genetic testing for patients diagnosed with ALS may help provide a better understanding of their condition and may help inform life choices, including family planning and potential clinical trial opportunities.4

May help inform risk

Genetic testing for asymptomatic family members may help inform individuals about their risk of developing the disease and may help inform similar life choices regarding long-term life decisions and family planning. DNA studies included in this program are not intended to be a diagnostic or screening test for the selected condition(s).5

Program eligibility

ALS Identified™ is open to all individuals 18 years or older within the US and Puerto Rico with

  • A diagnosis of ALS.

  • Or, a family history of, ALS. This includes patients with familial ALS as well as patients with seemingly sporadic ALS as genetic mutations have been found in people with ALS who have no known family history of the disease.

Woman smiling while providing genetic expert support

Genetic counseling services

Individuals in the US tested through the ALS Identified™ program are eligible for post-test genetic counseling to help them understand their test results. This service is made available by Invitae at no charge as part of the program. Patients can access genetic counseling by using an online scheduling option or by contacting Invitae Client Services at 1-800-436-3037 and asking to schedule a genetic counseling appointment.

Test options

This program offers testing with the following panel. Learn more about the panel in our test catalog before placing your order on this program page.

Kit options

How to order

Our easy-to-order panels align with professional guidelines, making your potential next steps clearer.

  • Step 1 duotone icon

    Step 1

    Discuss testing and get consent from the eligible patient. Place your order via our convenient online portal.

  • Step 2 duotone icon

    Step 2

    Collect your patient’s specimen using an Invitae collection kit and return it. Use the label provided to ship most samples at no additional charge from the US and Canada.

  • Genetic testing expert - Invitae icon

    Step 3

    Receive results online and access resources to guide your discussion with patient about their results.

See how it works

Next steps and additional services

About Biogen
At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.

References

1. Mehta P, Kaye W, Raymond J, et al. Prevalence of amyotrophic lateral sclerosis—United States, 2015. MMWR Morb Mortal Wkly Rep. 2018;67(46):1285-1289.
2. Gladman M, Zinman L. The economic impact of amyotrophic lateral sclerosis: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2015;15(3):439-450.
3. Roggenbuck J, Quick A, Kolb SJ. Genetic testing and genetic counseling for amyotrophic lateral sclerosis: an update for clinicians. Genet Med. 2017;19(3):267-274.
4. Shepheard SR, Parker MD, Cooper-Knock J, et al; on behalf of Project MINE Consortium; Project MinE. Value of systematic genetic screening of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2021;jnnp-2020-325014. doi:10.1136/jnnp-2020-325014.
5. Benatar M, Stanislaw C, Reyes E, et al. Presymptomatic ALS genetic counseling and testing: experience and recommendations. Neurology. 2016;86(24):2295-2302.

Disclaimer: This is a sponsored testing program. While third parties and commercial organizations may provide financial support for this program, tests and services are performed by Invitae. Healthcare professionals must confirm that patients meet certain criteria to use the program. Third parties and commercial organizations may receive de-identified (pseudonymized) patient data from this program, but at no time would they receive patient identifiable information. Third parties and commercial organizations may receive contact information for healthcare professionals who use this program. Genetic testing and counseling are available in the US. Healthcare professionals and patients who participate in this program have no obligation to recommend, purchase, order, prescribe, promote, administer, use or support any other products or services from Invitae or from third parties or commercial organizations.